Hikma Pharmaceutical | HIK - Loan Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Hikma Pharmaceutical

Hikma Pharmaceutical reported $1.14B in Loan Capital for its fiscal semester ending in December of 2022.


Loan Capital Change
Almirall SA ALM:SM EUR 387.16M 13.66M
Artemis Alpha ATS:LN GBP 0 0
AstraZeneca AZN:LN USD 27.65B 3.96B
Bayer BAYN:GR EUR 33.57B 220M
Galapagos GLPG:NA EUR 10.22M 4.47M
Genmab GEN:DC DKK 740M 217M
GlaxoSmithKline GSK:LN GBP 16.64B 391M
Hikma Pharmaceutical HIK:LN USD 1.14B 279M
Lonza Group LONN:SW CHF 1.55B 393M
Merck MRK:GR EUR 9.16B 41M
Orion ORNBV:FH EUR 189.7M 7.1M
Recordati REC:IM EUR 1.26B 77.57M
Roche Holding ROG:VX CHF 21.39B 978M
UCB UCB:BB EUR 2.64B 251M